The Role of Vitamin D and the Vitamin D Receptor in Oral Cancer: A Narrative Review
IOSR Journal of Dental and Medical Sciences · 2026-05 · 25 (5) · 80-85
DOI: 10.9790/0853-2505048085 ↗Kurz gefasst
Fachartikel in der Zeitschrift IOSR Journal of Dental and Medical Sciences, 2026-05. Verfasst von Saurjya Ranjan Das und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Oral cancer remains a major global public health concern, with oral squamous cell carcinoma (OSCC) accounting for more than 90% of all oral malignancies. Despite advances in therapy, prognosis remains poor due to delayed diagnosis and the limited availability of disease-specific biomarkers. Vitamin D and its nuclear receptor (VDR) have attracted considerable attention over the past two decades for their pleiotropic roles extending beyond calcium and phosphate homeostasis.
Objective
This narrative review summarises current evidence on the role of vitamin D and VDR in tumorigenesis, with particular emphasis on oral cancer, and examines the mechanisms underlying the anticancer effects of calcitriol, the regulation of VDR expression, the contribution of VDR gene polymorphisms, and the relationship between vitamin D status and chemoresistance.
Methods
Peer-reviewed literature published in English was identified through PubMed, Scopus, and Web of Science using combinations of the terms “vitamin D”, “vitamin D receptor”, “oral cancer”, “oral squamous cell carcinoma”, “calcitriol”, and “chemoprevention”. Relevant in vitro, in vivo, and clinical studies were reviewed.
Results
Vitamin D, predominantly in its active form 1α,25(OH)₂D₃ (calcitriol), exerts pro-apoptotic, antiproliferative, anti-angiogenic and anti-inflammatory effects on a wide range of cancer cells, including OSCC. VDR is expressed in many malignant tissues, and its expression has been correlated with tumour behaviour and treatment response. Epidemiological data suggest that low circulating 25-hydroxyvitamin D levels are associated with increased risk and mortality of several cancers, including head and neck squamous cell carcinoma. Calcitriol supplementation has been shown to enhance the efficacy of photodynamic therapy in preclinical models of squamous cell carcinoma.
Conclusion
Vitamin D and VDR represent promising targets for chemoprevention and adjuvant therapy in oral cancer. However, additional well-designed clinical trials are required to establish the therapeutic utility of vitamin D supplementation and to clarify the influence of VDR polymorphisms on individual susceptibility and treatment response.
Zitieren
APA
Das, S. R., & Champatyray, S. (2026). The Role of Vitamin D and the Vitamin D Receptor in Oral Cancer: A Narrative Review. IOSR Journal of Dental and Medical Sciences, 25(5), 80-85. https://doi.org/10.9790/0853-2505048085
Vancouver
Das SR, Champatyray S. The Role of Vitamin D and the Vitamin D Receptor in Oral Cancer: A Narrative Review. IOSR Journal of Dental and Medical Sciences. 2026;25(5):80-85. doi:10.9790/0853-2505048085
BibTeX
@article{Das2026,
author = {Das, Saurjya Ranjan and Champatyray, Sreepreeti},
title = {The Role of Vitamin D and the Vitamin D Receptor in Oral Cancer: A Narrative Review},
journal = {IOSR Journal of Dental and Medical Sciences},
year = {2026},
volume = {25},
number = {5},
pages = {80--85},
doi = {10.9790/0853-2505048085}
}
EUVIMED